A

Amgen

Makes biotech medicines for serious illnesses

Associate Director Quality Compliance - Inspection Lifecycle Management

Regulatory & Quality (Life Sciences)Posted on Nov 13
Full-timeJuncos, Puerto RicoIn-person

About the Job

Requirements

  • A doctorate degree and 3 years of regulatory compliance experience, or a master’s degree and 7 years of regulatory compliance experience, or a bachelor’s degree and 9 years of regulatory compliance experience, or an associate’s degree and 12 years of regulatory compliance experience, or a high school diploma or GED and 14 years of regulatory compliance experience.
  • At least 3 years of experience directly managing people and/or leading teams, projects, or programs, or directing resource allocation; this experience may run concurrently with the required technical experience.
  • A bachelor’s degree in Life Sciences or Engineering is preferred.
  • Seven or more years of related pharmaceutical industry experience in Manufacturing, Process Development, and/or Quality Assurance, with progressively increasing responsibility in compliance, data analysis, project management, and quality systems is preferred.
  • Experience preparing for, executing, responding to, auditing, and/or defending processes, procedures, and decisions during Health Authority inspections is preferred.
  • Thorough knowledge of U.S. and EU current Good Manufacturing Practices, quality management systems, and quality control processes related to bulk drug substance commercial operations is preferred.
  • Strong exposure to bulk drug substance manufacturing and quality assurance processes is preferred.
  • Demonstrated people leadership experience, preferably across functions and/or sites, including developing and leading strategic roles, networks, and successful teams, is preferred.
  • Experience leading and influencing cross-functional, global, and/or enterprise-level Quality or Compliance programs, including executive leadership communications, is preferred.
  • Demonstrated ability to lead cross-functional project teams and process improvement initiatives, delivering results on schedule and to expectations, is preferred.
  • Ability to work autonomously, navigate ambiguity, apply a structured problem-solving approach, and present data clearly and logically is preferred.
  • Ability to establish and maintain remote working relationships across Amgen sites to identify and align to standard processes is preferred.
  • Fluency in written and spoken English is preferred.

Responsibilities

  • Serve as the AML Inspection Lifecycle Management Drug Substance representative, partnering with the AML ILM Drug Product and Finished Drug Product representative to support preparation for, execution of, and response to Health Authority and Business Partner inspections.
  • Maintain an on-site Regulatory Compliance presence and collaborate across functions and sites to sustain traceable, continuous inspection readiness.
  • Provide guidance on regulatory compliance expectations and trends; support Regulatory Affairs and self-inspection (internal audit) programs; and lead efforts to resolve site compliance risks.
  • Perform and/or lead site inspection-readiness activities, including strategy sessions and pressure testing for higher-risk topics.
  • Support inspections through direct interaction with inspectors and participation in support rooms and other functions, guiding responses to inspector requests.
  • Advise on inspection-response development, ensuring observations and findings are addressed thoroughly with global scope and best practices considered.
  • Track commitments and improvement actions through completion and cascade inspection outcomes across Amgen sites and functions to enable learning and improvement.
  • Lead a network of ILM staff at Drug Substance processing sites, including at least three direct reports and at least two indirect reports at sites with Drug Substance processing in addition to Drug Product and/or Finished Drug Product.
  • Manage and develop direct reports by providing coaching, strategic direction, and compliance guidance.
  • Establish and deploy Drug Substance inspection-readiness maturity and performance standards across the ILM network.
  • Own and synthesize Drug Substance-specific inspection intelligence from internal inspection outcomes, external Health Authority trends, and emerging regulatory focus areas; identify risks, communicate them to responsible areas, and advise on prioritized mitigation and readiness strategies.
  • Partner with the centralized ILM Drug Product/Finished Drug Product network, the Global Process Owner for Inspections, and the Head of ILM to deliver an intelligence- and risk-based, end-to-end inspection-readiness program.
  • Identify, collect, and communicate best practices and improvement opportunities from inspection readiness, preparation, execution, and outcomes.
  • Support the Global Process Owner for Inspections in continuously improving and deploying inspection lifecycle tools, systems, and processes across ILM sites.
  • Serve as a Subject Matter Expert for applicable inspection lifecycle tools, systems, and processes.

About the Company

Amgen

Makes biotech medicines for serious illnesses

Amgen develops and makes biologic medicines, which are drugs built from proteins and antibodies grown in living cells, for serious conditions such as heart disease, cancer, and bone loss. Its anemia drug Epogen, approved in 1989, became one of the biotechnology industry's first blockbuster medicines. Amgen grows these drugs in large tanks called bioreactors, and its products include the cholesterol drug Repatha, the bone-building drug Evenity, and the severe asthma drug Tezspire. It earns money by selling these medicines, mostly through large drug wholesalers that supply hospitals and pharmacies. Amgen was founded in 1980 and is based in Thousand Oaks, California.

Company size
10,001+
Company stage
IPO
Headquarters
Thousand Oaks, CA
Founded
1980

Recently Posted Jobs

Explore more opportunities at Amgen

See more jobs